Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase
Clinical trial NCT01135524 · TERMINATED
Trial details
- NCT number
- NCT01135524
- Sponsor
- Purdue Pharma LP
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-08-01
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.